C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
260/264.7
C07D 237/04 (2006.01)
Patent
CA 1108614
O.Z. 32,647 ABSTRACT OF THE DISCLOSURE: 6-(p-Acylaminophenyl)-4,5-dihydropyridaz-3-ones of the formula I Image I where R1 is hydrogen or alkyl of 1 to 3 carbon atoms and R2, if R1 is hydrogen, is halogen-substituted alkyl of 3 to 6 carbon atoms or .beta.-haloethyl or, if R1 is alkyl of 1 to 3 carbon atoms, is halogen-substituted alkyl of 1 to 6 carbon atoms, their manu- facture, and therapeutlc agents which contain, as the active ingredient, a compound of the formula I, where R2 may also be halo- methyl or .alpha.-haloethyl if R1 is hydrogen. These compounds may be used as anti-hypertensive agents and for the prophylaxis and therapy of thrombo-embolic disorders.
305625
Gries Josef
Koenig Horst
Kunze Johannes
Lebkuecher Rolf
Lehmann Hans D.
Basf Aktiengesellschaft
Robic Robic & Associes/associates
LandOfFree
Dihydropyridazones, their manufacture, and therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydropyridazones, their manufacture, and therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydropyridazones, their manufacture, and therapeutic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-173596